Pim

Isoform-selective Products

Signaling Pathway

Pim Signaling Pathway

Pim Products

  • All (12)
  • Pim Inhibitors (12)
  • New Pim Products
Catalog No. Product Name Information Product Use Citations Product Validations
S2198 SGI-1776 free base SGI-1776 free base is a novel ATP competitive inhibitor of Pim1 with IC50 of 7 nM in a cell-free assay, 50- and 10-fold selective versus Pim2 and Pim3, also potent to Flt3 and haspin. SGI-1776 induces apoptosis and autophagy.
Cell Death Dis, 2024, 15(9):644
Mol Cancer, 2023, 22(1):64
Int J Mol Sci, 2023, 24(6)5464
S7104 AZD1208 AZD1208 is a potent, and orally available Pim kinase inhibitor with IC50 of 0.4 nM, 5 nM, and 1.9 nM for Pim1, Pim2, and Pim3 in cell-free assays, respectively. AZD1208 induces autophagy, cell cycle arrest and apoptosis. Phase 1.
Angiogenesis, 2024, 10.1007/s10456-024-09906-y
Cell Death Dis, 2024, 15(4):274
Inflamm Res, 2024, 10.1007/s00011-024-01924-2
S7985 PIM447 (LGH447) Hydrochloride PIM447 (LGH447) Hydrochloride is a novel pan-PIM kinase inhibitor with Ki values of 6 pM, 18 pM, 9 pM for PIM1, PIM2, PIM3 respectively. It also inhibits GSK3β, PKN1, and PKCτ, but at a significantly lower potency with IC50 between 1 and 5 μM (>105-fold differential relative to the Ki on PIMs). PIM447 induces apoptosis.
Oncogene, 2024, 43(6):406-419
NPJ Precis Oncol, 2024, 8(1):152
Antiviral Res, 2024, 226:105891
S8005 SMI-4a SMI-4a (TCS PIM-1 4a) is a potent inhibitor of Pim1 with IC50 of 17 nM, modestly potent to Pim-2, does not significantly inhibit any other serine/threonine- or tyrosine-kinases.
Transl Gastroenterol Hepatol, 2024, 9:14
J Transl Med, 2023, 21(1):452
Nat Commun, 2022, 13-1:5866
S7041 CX-6258 HCl CX-6258 HCl is a potent, orally efficacious pan-Pim kinase inhibitor with IC50 of 5 nM, 25 nM and 16 nM for Pim1, Pim2, and Pim3, respectively.
Elife, 2023, 12e69521
Nat Med, 2020, 10.1038/s41591-020-0926-0
Nat Commun, 2020, 29;11(1):2086
S8800 Uzansertib (INCB053914) Uzansertib (INCB053914) is a novel, ATP-competitive, small molecule, pan-inhibitor of PIM kinases with IC50 values of 0.24 nM, 30 nM and 0.12 nM for PIM1, PIM2 and PIM3 respectively in biochemical assays.
Antiviral Res, 2024, 226:105891
Cancer Lett, 2020, 476:23-33
Fish Shellfish Immunol, 2020, 99:86-98
S6774 TP-3654 TP-3654 is the second-generation PIM inhibitor with Ki values of 5 nM, 239 nM, and 42 nM for PIM-1, PIM-2 and PIM-3, respectively.
PLoS One, 2023, 10.1371/journal.pone.0294065
Int J Mol Sci, 2021, 22(17)9440
S3296 Hispidulin Hispidulin (Dinatin), an active natrual ingredient in a number of traditional Chinese medicinal herbs, exhibits inhibitory activity against the oncogenic protein kinase Pim-1 with IC50 of 2.71 μM. Hispidulin induces apoptosis through mitochondrial dysfunction and inhibition of P13k/Akt signalling pathway in HepG2 cancer cells. Hispidulin exerts anti-osteoporotic and bone resorption attenuating effects via activating the AMPK signaling pathway.
Evid Based Complement Alternat Med, 2023, 2023:9428241
S6497 SMI-16a SMI-16a is a selective Pim kinase inhibitor with IC50 values of 150 nM and 20 nM for Pim1 and Pim2 respectively.
J Cell Physiol, 2022, 10.1002/jcp.30814
E4598New MEN1703(SEL24,SEL24-B489) MEN1703(SEL24-B489,SEL24, Pim/flt3 kinase inhibitor SEL24) is a potent, type I, orally active, dual inhibitor of PIM and FLT3-ITD, that exhibits Kd values of 2 nM for PIM1, 2 nM for PIM2 and 3 nM for PIM3, respectively. MEN1703 exhibits its broad therapeutic potential in treatment of acute myeloid leukemia.
S1050 TCS PIM-1 1 TCS PIM-1 1 (SC 204330) is a potent and selective inhibitor of ATP-competitive Pim-1 kianse with IC50 of 50 nM, shows good selectivity over Pim-2 and MEK1/MEK2 with IC50 > 20000 nM.
E0675 Quercetagetin Quercetagetin (6-Hydroxyquercetin), a flavonoid, is a moderately potent and selective, cell-permeable Pim-1 kinase inhibitor with IC50 of 0.34 μM.
S2198 SGI-1776 free base SGI-1776 free base is a novel ATP competitive inhibitor of Pim1 with IC50 of 7 nM in a cell-free assay, 50- and 10-fold selective versus Pim2 and Pim3, also potent to Flt3 and haspin. SGI-1776 induces apoptosis and autophagy.
Cell Death Dis, 2024, 15(9):644
Mol Cancer, 2023, 22(1):64
Int J Mol Sci, 2023, 24(6)5464
S7104 AZD1208 AZD1208 is a potent, and orally available Pim kinase inhibitor with IC50 of 0.4 nM, 5 nM, and 1.9 nM for Pim1, Pim2, and Pim3 in cell-free assays, respectively. AZD1208 induces autophagy, cell cycle arrest and apoptosis. Phase 1.
Angiogenesis, 2024, 10.1007/s10456-024-09906-y
Cell Death Dis, 2024, 15(4):274
Inflamm Res, 2024, 10.1007/s00011-024-01924-2
S7985 PIM447 (LGH447) Hydrochloride PIM447 (LGH447) Hydrochloride is a novel pan-PIM kinase inhibitor with Ki values of 6 pM, 18 pM, 9 pM for PIM1, PIM2, PIM3 respectively. It also inhibits GSK3β, PKN1, and PKCτ, but at a significantly lower potency with IC50 between 1 and 5 μM (>105-fold differential relative to the Ki on PIMs). PIM447 induces apoptosis.
Oncogene, 2024, 43(6):406-419
NPJ Precis Oncol, 2024, 8(1):152
Antiviral Res, 2024, 226:105891
S8005 SMI-4a SMI-4a (TCS PIM-1 4a) is a potent inhibitor of Pim1 with IC50 of 17 nM, modestly potent to Pim-2, does not significantly inhibit any other serine/threonine- or tyrosine-kinases.
Transl Gastroenterol Hepatol, 2024, 9:14
J Transl Med, 2023, 21(1):452
Nat Commun, 2022, 13-1:5866
S7041 CX-6258 HCl CX-6258 HCl is a potent, orally efficacious pan-Pim kinase inhibitor with IC50 of 5 nM, 25 nM and 16 nM for Pim1, Pim2, and Pim3, respectively.
Elife, 2023, 12e69521
Nat Med, 2020, 10.1038/s41591-020-0926-0
Nat Commun, 2020, 29;11(1):2086
S8800 Uzansertib (INCB053914) Uzansertib (INCB053914) is a novel, ATP-competitive, small molecule, pan-inhibitor of PIM kinases with IC50 values of 0.24 nM, 30 nM and 0.12 nM for PIM1, PIM2 and PIM3 respectively in biochemical assays.
Antiviral Res, 2024, 226:105891
Cancer Lett, 2020, 476:23-33
Fish Shellfish Immunol, 2020, 99:86-98
S6774 TP-3654 TP-3654 is the second-generation PIM inhibitor with Ki values of 5 nM, 239 nM, and 42 nM for PIM-1, PIM-2 and PIM-3, respectively.
PLoS One, 2023, 10.1371/journal.pone.0294065
Int J Mol Sci, 2021, 22(17)9440
S3296 Hispidulin Hispidulin (Dinatin), an active natrual ingredient in a number of traditional Chinese medicinal herbs, exhibits inhibitory activity against the oncogenic protein kinase Pim-1 with IC50 of 2.71 μM. Hispidulin induces apoptosis through mitochondrial dysfunction and inhibition of P13k/Akt signalling pathway in HepG2 cancer cells. Hispidulin exerts anti-osteoporotic and bone resorption attenuating effects via activating the AMPK signaling pathway.
Evid Based Complement Alternat Med, 2023, 2023:9428241
S6497 SMI-16a SMI-16a is a selective Pim kinase inhibitor with IC50 values of 150 nM and 20 nM for Pim1 and Pim2 respectively.
J Cell Physiol, 2022, 10.1002/jcp.30814
E4598New MEN1703(SEL24,SEL24-B489) MEN1703(SEL24-B489,SEL24, Pim/flt3 kinase inhibitor SEL24) is a potent, type I, orally active, dual inhibitor of PIM and FLT3-ITD, that exhibits Kd values of 2 nM for PIM1, 2 nM for PIM2 and 3 nM for PIM3, respectively. MEN1703 exhibits its broad therapeutic potential in treatment of acute myeloid leukemia.
S1050 TCS PIM-1 1 TCS PIM-1 1 (SC 204330) is a potent and selective inhibitor of ATP-competitive Pim-1 kianse with IC50 of 50 nM, shows good selectivity over Pim-2 and MEK1/MEK2 with IC50 > 20000 nM.
E0675 Quercetagetin Quercetagetin (6-Hydroxyquercetin), a flavonoid, is a moderately potent and selective, cell-permeable Pim-1 kinase inhibitor with IC50 of 0.34 μM.
E4598New MEN1703(SEL24,SEL24-B489) MEN1703(SEL24-B489,SEL24, Pim/flt3 kinase inhibitor SEL24) is a potent, type I, orally active, dual inhibitor of PIM and FLT3-ITD, that exhibits Kd values of 2 nM for PIM1, 2 nM for PIM2 and 3 nM for PIM3, respectively. MEN1703 exhibits its broad therapeutic potential in treatment of acute myeloid leukemia.

Choose Selective Pim Inhibitors

Tags: Pim inhibitor|Pim agonist|Pim activator|Pim inducer|Pim antagonist|Pim signaling pathway|Pim assay kit